Glenda Halliday < Glenda M. Halliday < Glenda Margaret Halliday

Facettes :

List of bibliographic references indexed by Glenda M. Halliday

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]

Ident.	Authors (with country if any)	Title
000069 (2015)	Perdita Cheshire [Australie] ; Scott Ayton [Australie] ; Kelly L. Bertram [Australie] ; Helen Ling [Royaume-Uni] ; Abi Li [Royaume-Uni] ; Catriona Mclean [Australie] ; Glenda M. Halliday [Australie] ; Sean S. O'Sullivan [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; David I. Finkelstein [Australie] ; Elsdon Storey [Australie] ; David R. Williams [Australie]	Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
000151 (2015)	Heather Mccann [Australie] ; Heidi Cartwright [Australie] ; Glenda M. Halliday [Australie]	Neuropathology of α-synuclein propagation and braak hypothesis.
000181 (2015)	Karen E. Murphy [Australie] ; Amanda M. Gysbers [Australie] ; Sarah K. Abbott [Australie] ; Adena S. Spiro [Australie] ; Akiko Furuta [Japon] ; Antony Cooper [Australie] ; Brett Garner [Australie] ; Tomohiro Kabuta [Japon] ; Glenda M. Halliday [Australie]	Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.
000363 (2014)	Alana J. Muller [Australie] ; James M. Shine ; Glenda M. Halliday ; Simon J G. Lewis	Visual hallucinations in Parkinson's disease: theoretical models.
000374 (2014)	Daniela Berg [Allemagne] ; Ronald B. Postuma [Canada] ; Bastiaan Bloem [Pays-Bas] ; Piu Chan [République populaire de Chine] ; Bruno Dubois [France] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Glenda M. Halliday [Australie] ; John Hardy [Royaume-Uni] ; Anthony E. Lang [Canada] ; Irene Litvan [États-Unis] ; Kenneth Marek [États-Unis] ; José Obeso [Espagne] ; Wolfgang Oertel [Allemagne] ; C Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Matthew Stern [États-Unis] ; Günther Deuschl [Allemagne]	Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease
000398 (2014)	Glenda M. Halliday [Australie] ; James B. Leverenz [États-Unis] ; Jay S. Schneider [États-Unis] ; Charles H. Adler [États-Unis]	The Neurobiological Basis of Cognitive Impairment in Parkinson'S Disease
000612 (2014)	A Jon Stoessl [Canada] ; Glenda M. Halliday	DAT-SPECT diagnoses dopamine depletion, but not PD.
000667 (2014)	Sarah K. Abbott ; Hongyun Li ; Sonia Sanz Mu Oz ; Bianca Knoch ; Marijka Batterham ; Karen E. Murphy ; Glenda M. Halliday ; Brett Garner	Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.
000705 (2013)	Stefanie Reyes [Australie] ; Veronica Cottam ; Deniz Kirik ; Kay L. Double ; Glenda M. Halliday	Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra.
000A41 (2013)	Kirsten G. Coupland [Australie] ; Goerge D. Mellick [Australie] ; Peter A. Silburn [Australie] ; Karen Mather [Australie] ; Nicola J. Armstrong [Australie] ; Perminder S. Sachdev [Australie] ; Henry Brodaty [Australie] ; Yue Huang [Australie] ; Glenda M. Halliday [Australie] ; Marianne Hallupp [Australie] ; Woojin S. Kim [Australie] ; Carol Dobson-Stone [Australie] ; John B. J. Kwok [Australie]	DNA Methylation of MAPT Gene in Parkinson's Disease Cohorts and Modulation by Vitamin E In Vitro
000A45 (2013)	Sharon Kemp [Australie] ; Antony J. Harding ; Glenda M. Halliday ; Neil Mahant ; Victor S C. Fung	Cortical limb myoclonus in pathologically proven progressive supranuclear palsy.
000C14 (2012)	Raymond S. Schwartz [Australie] ; Glenda M. Halliday ; Dennis J. Cordato ; Jillian J. Kril	Small-vessel disease in patients with Parkinson's disease: a clinicopathological study.
000D28 (2012)	David A. Elliott [Australie] ; Woojin S. Kim ; Sarsha Gorissen ; Glenda M. Halliday ; John B J. Kwok	Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease.
000F81 (2012)	Raymond S. Schwartz [Australie] ; Glenda M. Halliday [Australie] ; Dennis J. Cordato [Australie] ; Jillian J. Kril [Australie]	Small-Vessel Disease in Patients with Parkinson's Disease: A Clinicopathological Study
001074 (2012)	David A. Elliott [Australie] ; Woojin S. Kim [Australie] ; Sarsha Gorissen [Australie] ; Glenda M. Halliday [Australie] ; John B. J. Kwok [Australie]	Leucine-Rich Repeat Kinase 2 and Alternative Splicing in Parkinson's Disease
001279 (2011)	James M. Shine [Australie] ; Glenda M. Halliday [Australie] ; Sharon L. Naismith [Australie] ; Simon J. G. Lewis [Australie]	Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?
001647 (2011)	Glenda M. Halliday [Australie] ; Claire H. Stevens [Australie]	Glia: Initiators and progressors of pathology in Parkinson's disease
001731 (2011)	Emma C. Schofield [Australie] ; John R. Hodges [Australie] ; Virginia Macdonald [Australie] ; Nicholas J. Cordato [Australie] ; Jillian J. Kril [Australie] ; Glenda M. Halliday [Australie]	Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy
002087 (2009)	Linda Truong [Australie] ; Daniel Brooks [Australie] ; Fabricio Amaral [Australie] ; Jasmine M. Henderson [Australie] ; Glenda M. Halliday [Australie]	Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia
002212 (2009)	Prachi Mehta [Australie] ; George D. Mellick [Australie] ; Dominic B. Rowe [Australie] ; Glenda M. Halliday [Australie] ; Michael M. Jones [Australie] ; Neil Manwaring [Australie] ; Himesha Vandebona [Australie] ; Peter A. Silburn [Australie] ; Jie Jin Wang [Australie] ; Paul Mitchell [Australie] ; Carolyn M. Sue [Australie]	Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community
002351 (2009)	Greg T. Sutherland [Australie] ; Glenda M. Halliday [Australie] ; Peter A. Silburn [Australie] ; Frank L. Mastaglia [Australie] ; Dominic B. Rowe [Australie] ; Richard S. Boyle [Australie] ; John D. O'Sullivan [Australie] ; Tina Ly [Australie] ; Steve D. Wilton [Australie] ; George D. Mellick [Australie]	Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Glenda M. Halliday" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Glenda M. Halliday" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Glenda M. Halliday
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024